US 9655909
Personalized medicine for the prediction of therapy targeting the hedgehog pathway
granted A61KA61K31/4355A61K31/436
Quick answer
US patent 9655909 (Personalized medicine for the prediction of therapy targeting the hedgehog pathway) held by The Board of Regents of the University of Texas System expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/4355, A61K31/436, A61K31/438, A61K31/439